Risk factors for development of status epilepticus in dogs with idiopathic epilepsy and effects of status epilepticus on outcome and survival time: 32 Cases (1990-1996)

Journal of the American Veterinary Medical Association

Volumn 219, Issue 5, 2001, Pages 618-623

  Saito, Miyoko ^a   Muñana, Karen R ^a   Sharp, Nicholas J H ^a   Olby, Natasha J ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CLORAZEPATE; PHENOBARBITAL; POTASSIUM BROMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOG; EPILEPTIC STATE; IDIOPATHIC DISEASE; LIFESPAN; NONHUMAN; OUTCOMES RESEARCH; RETROSPECTIVE STUDY; RISK FACTOR; SEIZURE; STATISTICAL ANALYSIS; SURVIVAL TIME;

ANIMALIA; CANIS FAMILIARIS;

EID: 0342902123     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2001.219.618     Document Type: Article

References (33)

1. Bunch SE. Anticonvulsant drug therapy in companion animals. In: Kirk RE, ed. Current veterinary therapy IX. Philadelphia: WB Saunders Co, 1986;836-844.
2. Shwartz-Porsche D. Epidemiological, clinical and pharmacokinetic studies in spontaneously epileptic dogs and cats, in Proceedings. 4th Annu Vet Med Forum 1986;11-61-11-63.
3. Podell M, Fenner WR, Powers JD. Seizure classification in dogs from a nonreferral-hased population. J Am Vet Med Assoc 1995; 206:1721-1728.
4. Jaggy A, Bernardini M. Idiopathic epilepsy in 125 dogs: a long-term study. Clinical and electroencephalographic findings. J Small Anim Pract 1998;39:23-29.
5. Shell L. Status epilepticus: pathophysiology, causes, and complications. Vet Med 1999;94:806-813.
6. Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med 1998;338:970-976.
7. Fountain NB, Lothman EW. Pathophysiology of status epilepticus. J Clin Neurophysiol 1995;12:326-342.
8. Bateman SW, Parent JM. Clinical findings, treatment, and outcome of dogs with status epilepticus or cluster seizures: 156 cases (1990-1995). J Am Vet Med Assoc 1999;215:1463-1468.
9. Commission on classification and terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.
10. Shorvon S. Prognosis and outcome of status epilepticus. In: Shorvon S, ed. Status epilepticus. Cambridge, England: Cambridge University Press, 1994;293-301.
11. Raw ML, Gaskell CJ. A review of one hundred cases of presumed canine epilepsy. J Small Anim Pract 1985;26:645-652.
12. Bozic K, Zikic M, Misic-Pavkov G, et al. Occurrence, causes and clinical characteristics of status epilepsy in adults. Med Pregl 1998;51:254-258.
13. Towne AR, Pellock JM, Ko D, et al. Determinants of mortality in status epilepticus. Epilepsia 1994;35:27-34.
14. DeLorenzo RJ, Pellock JM, Towne AR, et al. Epidemiology of status epilepticus. J Clin Neurophysiol 1995;12:316-325.
15. Srenk P, Jaggy A, Gaillard C, et al. Genetische grundlagen der idiopathischen epilepsie beim Golden Retriever. Tierarztl Prax 1994;22:574-578.
16. Okuma T, Kumashiro H. Natural history and prognosis of epilepsy: report of a multi-institutional study in Japan. Epilepsia 1981;22:35-53.
17. Elwes RDC, Johnson AL, Shorvon SD, et al. The prognosis for seizure control in newly diagnosed epilepsy. N Engl J Med 1984;311:944-947.
18. Casetta I, Granieri E, Monetti VC, et al. Prognosis of childhood epilepsy: a community-based study in Copparo, Italy. Neuroepidemiology 1997;16:22-28.
19. Kwan P, Brodie M J. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-319.
20. Reynolds EH. Do anticonvulsants alter the natural course of epilepsy? Treatment should be started as early as possible. BMJ 1995;310:176-177.
21. Hauser WA, Rich SS, Annegers JF, et al. Seizure recurrence after a 1st unprovoked seizure: an extended follow-up. Neurology 1990;40:1163-1170.
22. Hauser WA. Status epilepticus: epidemiologic considerations. Neurology 1990;40(suppl 2):9-13.
23. Heynold Y, Faissler D, Steffen F, et al. Clinical, epidemiological and treatment results of idiopathic epilepsy in 54 Labrador Retrievers: a long-term study. J Small Anim Pract 1997;38:7-14.
24. Schwartz-Porsche D, Loscher W, Frey HH. Therapeutic efficacy of phenobarbital and primidone in canine epilepsy: a comparison.; J Vet Pharmacol Ther 1985;8:113-119.
25. Boothe DM. Anticonvulsant therapy in small animals. Vet Clin North Am Small Anim Pract 1998;28:411-448.
26. Sisson A. Current experiences with anticonvulsants in dogs and cats, in Proceedings. 15th Annu Vet Med Forum 1997;596-598.
27. Trepanier LA. Optimal bromide therapy and monitoring, in Proceedings. 15th Annu Vet Med Forum 1997;100-101.
28. Podell M, Fenner WR. Bromide therapy in refractory canine idiopathic epilepsy. J Vet Intern Med 1993;7:318-327.
29. Olafsson E, Hauser WA, Gudmundsson G. Long-term survival of people with unprovoked seizures: a population-based study. Epilepsia 1998;39:89-92.
30. Cockerell OC, Johnson AL, Sander WAS, et al. Prognosis of epilepsy: a review and further analysis of the first nine years of the British national general practice study of epilepsy, a prospective population-based study. Epilepsia 1997;38:31-46.
31. Kraft W. Geriatrics in canine and feline internal medicine. Eur J Med Res 1998;3:31-41.
32. Sillanpää M, Jalava M, Shinnar S. Epilepsy syndromes in patients with childhood-onset seizures in Finland. Pediatr Neurol 1999;21:533-537.
33. Knowles K. Idiopathic epilepsy. Clin Tech Small Anim Pract 1999;13:144-151.